Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02118571 · ClinicalTrials.gov registry record
Schizophrenia Cognition Scale Development
A clinical trial, sponsored by Carelon Research.
- Completed
- Registry status
- 102
- Enrollment target
NCT02118571 is a clinical trial that has completed, run by Carelon Research. The registered enrollment target is 102 participants.
The verdict
NCT02118571 has completed, sponsored by Carelon Research.
- COMPLETED
- Registry status
- 102 participants
- Enrollment target
Study Summary
The objective of this protocol is to develop items for a patient-reported outcome (PRO) measure to assess the patient's perspective and subjective experience of cognitive impairment associated with schizophrenia (CIAS).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2013-11 |
| Est. Completion | 2016-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02118571
The ClinicalTrials.gov registry entry for NCT02118571 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carelon Research, which has 50 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02118571 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02118571 about?
NCT02118571 is a clinical study titled "Schizophrenia Cognition Scale Development". The objective of this protocol is to develop items for a patient-reported outcome (PRO) measure to assess the patient's perspective and subjective experience of cognitive impairment associated with schizophrenia (CIAS).
What is the current status of trial NCT02118571?
This trial is currently completed. The enrollment target is 102 participants. The study started on 2013-11. Estimated completion is 2016-07.
Who is sponsoring clinical trial NCT02118571?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.